Tuesday, November 24, 11:12 pm IST
| Feedback
Moneycontrol » News Center » Business » Business
Wockhardt's insulin brand Wosulin in trouble
Published on Wed, Nov 22, 2006 at 08:59   |  Updated at Wed, Nov 22, 2006 at 10:20  |  Source : Moneycontrol.com

Drugmaker Wockhardt's insulin brand ‘Wosulin’ is in trouble. CNBC-TV18 reports that the state food and drug administration has directed Wockhardt to immediately withdraw all stocks of the Wosluin brand on the basis of complaints received from consumers.

 


The State FDA sources said that FDA is yet to do its own examination, but Wosulin samples have been already been sent to the central research institute in Kasauli, Himachal Pradesh.

 

The exact reason for withdrawing the stock is unknown, but some sources point out that there could be manufacturing issues with Wosulin. Wockhardt officials declined to comment on the development.

 

 

 

 

Important Links Today:  Leadership Wall    Chat Calendar    The 10 List   
WHAT OTHERS LIKE
  • Most Read
  • Most Viewed
24 Hours
7 Days
1 Month
©Network 18, 2009. All Rights Reserved